...
首页> 外文期刊>International journal of gynecological cancer: official journal of the International Gynecological Cancer Society >Oncologic results and surgical morbidity of laparoscopic nerve-sparing radical hysterectomy in the treatment of FIGO stage IB cervical cancer: long-term follow-up.
【24h】

Oncologic results and surgical morbidity of laparoscopic nerve-sparing radical hysterectomy in the treatment of FIGO stage IB cervical cancer: long-term follow-up.

机译:腹腔镜保留神经的根治性子宫切除术在FIGO IB期宫颈癌的治疗中的肿瘤学结果和手术发病率:长期随访。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVES: The aim of this study was to evaluate a long-term follow-up data for oncologic results and surgical morbidity of a laparoscopic nerve-sparing radical hysterectomy (NSRH) in the treatment of FIGO stage IB cervical cancer. METHODS: This was a retrospective study that comprised consecutive 125 patients with cervical cancer stage IB1 (n = 105) and IB2 (n = 20) who underwent a laparoscopic NSRH (Piver type III) by a gynecologic oncologist without selecting patients from January 1999 to December 2007. RESULTS: In regression analysis, the operating time (R linear = 0.311, P < 0.001) and estimated blood loss (R linear = 0.261, P < 0.001) were decreased, whereas the number of harvested pelvic lymph nodes (R linear = 0.250, P < 0.001) was increased. Seventeen patients (13.6%, 17/125) were found to have pelvic node metastasis. Para-aortic node metastasis had occurred in 2 patients (5.1%, 2/39). There were high urological complications (13/125, 10.4%) related to radical surgery. Forty-one patients (33%) needed transfusions. Positive surgical margins did not exist. Patients were able to self-void at a mean of 10.3 days postoperatively. The return rates to normal voiding function at postoperative 14 and 21 days were 92.0% and 95.2%, respectively. Thirteen patients (IB1 n = 9, IB2 n = 4) experienced a recurrence postoperatively. Six patients (IB1 n = 3, IB2 n = 3) died of recurrent disease. Five-year disease-free survival rates of cervical cancer IB1 and IB2 were 92% and 78%, respectively (P = 0.1772). Five-year overall survival rates of cervical cancer IB1 and IB2 were 96% and 83%, respectively (P = 0.0437). CONCLUSIONS: A laparoscopic NSRH for FIGO stage IB cervical cancer was comparable to open NSRH in terms of early recovery of bladder function. It did not compromise surgical radicality, but revealed high urological complications, long operating time, and much blood loss, compared with conventional radical hysterectomy. However, these surgical morbidities were corrected with increase in experiences.
机译:目的:本研究的目的是评估腹腔镜保神经根治性子宫切除术(NSRH)在FIGO IB期宫颈癌的治疗中的肿瘤学结果和手术发病率的长期随访数据。方法:这是一项回顾性研究,该研究包括连续的125例宫颈癌IB1期(n = 105)和IB2期(n = 20)的患者,由妇科肿瘤科医生接受了腹腔镜NSRH(Piver III型)治疗,从1999年1月至2007年结果:在回归分析中,手术时间(R线性= 0.311,P <0.001)和估计的失血量(R线性= 0.261,P <0.001)减少了,而盆腔淋巴结的数目却减少了(R线性= 0.250,P <0.001)增加。发现十七名患者(13.6%,17/125)患有盆腔淋巴结转移。 2例患者发生主动脉旁结转移(5.1%,2/39)。与根治性手术有关的泌尿外科并发症较高(13 / 125,10.4%)。 41名患者(33%)需要输血。阳性切缘不存在。病人平均可以在术后10.3天自我戒断。术后14天和21天,正常排尿功能的恢复率分别为92.0%和95.2%。十三例患者(IB1 n = 9,IB2 n = 4)术后复发。六名患者(IB1 n = 3,IB2 n = 3)死于复发性疾病。宫颈癌IB1和IB2的五年无病生存率分别为92%和78%(P = 0.1772)。子宫颈癌IB1和IB2的五年总生存率分别为96%和83%(P = 0.0437)。结论:就膀胱功能的早期恢复而言,用于FIGO期IB期宫颈癌的腹腔镜NSRH与开放性NSRH相当。与常规的根治性子宫切除术相比,它没有损害手术的彻底性,但显示出泌尿外科并发症高,手术时间长和失血多。但是,随着经验的增加,这些手术的发病率得到了纠正。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号